Abraham Teunissen | Immunology | Best Researcher Award

Dr. Abraham Teunissen | Immunology | Best Researcher Award

Dr. Abraham Teunissen, Icahn school of medicine, United States.

Dr. Abraham J. P. Teunissen ๐ŸŽ“ is an Assistant Professor at the Biomedical Engineering and Imaging Institute, Icahn School of Medicine, New York ๐Ÿ—ฝ. He leads groundbreaking research in nanomedicine, radiochemistry, and immunotherapy ๐Ÿงฌ. With a Ph.D. in Molecular Engineering, he has authored high-impact studies and holds key patents. Dr. Teunissen mentors future scientists ๐Ÿ‘จโ€๐Ÿ”ฌ๐Ÿ‘ฉโ€๐Ÿ”ฌ and champions diversity and inclusion. His work on trained immunity and advanced imaging technologies is shaping the future of personalized medicine ๐ŸŒŸ.

๐ŸŒŸ Professional Profile

๐ŸŽ“Early Academic Pursuitsย 

Abraham J. P. Teunissen, Ph.D., embarked on his academic journey at Fontys University of Applied Science, earning a B.ASc in Organic Chemistry in 2011, where he developed supramolecular polymers for improved hemodialysis. He continued at Eindhoven University of Technology, securing an M.Sc. in Molecular Engineering (2013) and completing a Ph.D. (2017) focused on competing interactions in chemical reaction networks. His early research on biomimetic systems and chemical networks laid the foundation for a distinguished career in biomedical sciences.

๐ŸขProfessional Endeavorsย 

Dr. Teunissenโ€™s professional journey showcases a trajectory of growth and leadership. He held appointments at the prestigious Icahn School of Medicine at Mount Sinai, progressing from Postdoctoral Scientist (2017) to Instructor (2019), and ultimately to Assistant Professor (2022). He also serves as the Director of Radiochemistry at the Biomedical Engineering and Imaging Institute. Beyond academia, he consulted for Trained Therapeutix Discovery, driving translational innovation from 2019 to 2021.

๐Ÿ”ฌContributions and Research Focus On Immunologyย 

Dr. Teunissen has made notable contributions to nanomedicine, immunology, and molecular imaging. His research lab develops novel nanotherapies and imaging probes to modulate and monitor the immune system in various diseases โ€” including cancer, cardiovascular disease, diabetes, and organ transplantation. His teamโ€™s work spans small and large animal models, advancing therapeutic strategies with clinical relevance. His radiochemistry facility supports diverse collaborations, innovating nanoparticle tracking and immune monitoring using immuno-PET technology.

๐ŸŒŽImpact and Influenceย 

The outcomes of Dr. Teunissen’s research have wide-reaching impacts. His lab’s pioneering work on trained immunity modulation has driven forward collaborations, clinical translation efforts, and even the founding of a biotech company, Trained Therapeutix Discovery. His immuno-PET technologies enhance understanding of disease mechanisms and inform therapeutic interventions, demonstrating translational significance from bench to bedside.

๐Ÿ“šAcademic Cites and High-Impact Publicationsย 

Dr. Teunissen’s work has appeared in leading journals such as Cell, Nature Biomedical Engineering, Nature Nanotechnology, and Science Translational Medicine. His high citation count reflects the significance of his research, especially in trained immunity, nanomedicine, and molecular imaging fields. These citations highlight his contributions to both fundamental science and applied biomedical research.

๐Ÿ†Awards and Honorsย 

While specific individual awards were not detailed, Dr. Teunissen’s achievements include serving as an ad-hoc NIH and American Cancer Society grant reviewer, organizing major scientific symposia, and designing graduate-level coursework. His leadership roles โ€” like incident commander and scientific advisory organizer โ€” reflect high institutional trust and professional recognition.

๐Ÿ”ฎLegacy and Future Contributionsย 

Dr. Teunissenโ€™s legacy is rooted in scientific excellence, mentorship, and innovation. With an active lab mentoring a diverse group of postdocs, graduate, and premedical students, he is shaping the next generation of biomedical engineers and nanomedicine scientists. His future contributions are expected to further bridge fundamental science and clinical application, aiming to improve therapeutic outcomes for major diseases through immune modulation and advanced molecular imaging. His strong commitment to diversity, inclusion, and education ensures a lasting positive impact on both science and society.

๐Ÿ“šPublications Top Notes

  • Development of Methods for the Determination of pKa Values
    ๐Ÿ“ฐ Analytical Chemistry Insights | ๐Ÿ“‘ 483 citations | ๐Ÿ“… 2013

  • Investigating Supramolecular Systems Using Fรถrster Resonance Energy Transfer
    ๐Ÿ“ฐ Chemical Society Reviews | ๐Ÿ“‘ 159 citations | ๐Ÿ“… 2018

  • Trained Immunity-Promoting Nanobiologic Therapy Suppresses Tumor Growth and Potentiates Checkpoint Inhibition
    ๐Ÿ“ฐ Cell | ๐Ÿ“‘ 145 citations | ๐Ÿ“… 2020

  • Efficacy and Safety Assessment of a TRAF6-Targeted Nanoimmunotherapy in Atherosclerotic Mice and Non-Human Primates
    ๐Ÿ“ฐ Nature Biomedical Engineering | ๐Ÿ“‘ 128 citations | ๐Ÿ“… 2018

  • End Groups of Functionalized Siloxane Oligomers Direct Block-Copolymeric or Liquid-Crystalline Self-Assembly Behavior
    ๐Ÿ“ฐ Journal of the American Chemical Society | ๐Ÿ“‘ 110 citations | ๐Ÿ“… 2016

  • Tumor Targeting by ฮฑvฮฒ3-Integrin-Specific Lipid Nanoparticles Occurs via Phagocyte Hitchhiking
    ๐Ÿ“ฐ ACS Nano | ๐Ÿ“‘ 93 citations | ๐Ÿ“… 2020

  • Directing the Selfโ€Assembly Behaviour of Porphyrinโ€Based Supramolecular Systems
    ๐Ÿ“ฐ Chemistry โ€“ A European Journal | ๐Ÿ“‘ 82 citations | ๐Ÿ“… 2017

  • Imaging-Assisted Nanoimmunotherapy for Atherosclerosis in Multiple Species
    ๐Ÿ“ฐ Science Translational Medicine | ๐Ÿ“‘ 68 citations | ๐Ÿ“… 2019

  • Prosaposin Mediates Inflammation in Atherosclerosis
    ๐Ÿ“ฐ Science Translational Medicine | ๐Ÿ“‘ 65 citations | ๐Ÿ“… 2021

  • Nuclear Imaging Approaches Facilitating Nanomedicine Translation
    ๐Ÿ“ฐ Advanced Drug Delivery Reviews | ๐Ÿ“‘ 63 citations | ๐Ÿ“… 2020

  • Probing Myeloid Cell Dynamics in Ischaemic Heart Disease by Nanotracer Hot-Spot Imaging
    ๐Ÿ“ฐ Nature Nanotechnology | ๐Ÿ“‘ 61 citations | ๐Ÿ“… 2020

  • Mechanically Induced Gelation of a Kinetically Trapped Supramolecular Polymer
    ๐Ÿ“ฐ Macromolecules | ๐Ÿ“‘ 52 citations | ๐Ÿ“… 2014

  • Imaging Cardiovascular and Lung Macrophages with the Positron Emission Tomography Sensor 64Cu-Macrin in Mice, Rabbits, and Pigs
    ๐Ÿ“ฐ Circulation: Cardiovascular Imaging | ๐Ÿ“‘ 44 citations | ๐Ÿ“… 2020

  • Resolving Sepsis-Induced Immunoparalysis via Trained Immunity by Targeting Interleukin-4 to Myeloid Cells
    ๐Ÿ“ฐ Nature Biomedical Engineering | ๐Ÿ“‘ 37 citations | ๐Ÿ“… 2023

  • A Modular Approach Toward Producing Nanotherapeutics Targeting the Innate Immune System
    ๐Ÿ“ฐ Science Advances | ๐Ÿ“‘ 35 citations | ๐Ÿ“… 2021

  • An Iterative Sparse Deconvolution Method for Simultaneous Multicolor 19Fโ€MRI of Multiple Contrast Agents
    ๐Ÿ“ฐ Magnetic Resonance in Medicine | ๐Ÿ“‘ 30 citations | ๐Ÿ“… 2020

ย 

Eun Sook Hwang | Immunology | Best Researcher Award

Prof. Eun Sook Hwang | Immunology | Best Researcher Awardย 

Prof. Eun Sook Hwang, Ewha Womans University, South Korea.

Professor. Eun Sook Hwang is a distinguished researcher at Ewha Womans University, specializing in immunology, cell biology, and pharmacology. With 12 national research projects, 105 SCI(E) publications, and an H-index of 35, her work has significantly advanced immune regulation, inflammation, and tissue regeneration studies. She has authored two books, collaborated globally with leading scientists, and serves as an editor for Frontiers in Bioscience-Landmark and Diseases & Research. As Chairperson of the Academic Committee of the Korean Pharmaceutical Society and President of the Woman Bioscience Forum, she is dedicated to mentoring young scientists and driving impactful biomedical research.

Professional Profile:

๐ŸŒŸSuitability for Best Researcher Award

Professor. Eun Sook Hwang is a distinguished researcher with a prolific academic and scientific record in immunology, pharmacology, and regenerative medicine. Her extensive contributions include 105 SCI-indexed publications, 12 nationally funded research projects, and significant industry collaborations. With a citation index of 4,867 and an H-index of 35, her impact on the field is evident. She has also contributed through editorial roles, leadership positions, and global collaborations. Her groundbreaking work in immune regulation, T-cell differentiation, and therapeutic development has propelled advancements in autoimmune disease and cancer research.

Professor. Hwangโ€™s exemplary research output, leadership in scientific communities, and dedication to mentoring future researchers make her a highly suitable candidate for the Best Researcher Award.

๐ŸŽ“ย Educational Background:

Professor. Eun Sook Hwang holds a distinguished academic background in biosciences, specializing in immunology, cell biology, and pharmacology. She earned her doctoral degree in pharmaceutical sciences, focusing on molecular mechanisms of immune regulation and inflammation. Her academic journey has been marked by rigorous research and a commitment to advancing biomedical knowledge. Through extensive training and specialization, she has developed expertise in transcription factors, T-cell differentiation, and tissue regeneration. Her education has laid a strong foundation for her prolific research career, leading to numerous high-impact publications, global collaborations, and leadership roles in academic and scientific organizations.

๐Ÿ’ผ Professionalย Experience:

Professor. Eun Sook Hwang has an extensive professional background in immunology, cell biology, and pharmacology, currently serving as a professor at Ewha Womans University. She has led 12 national research projects, contributed to over 105 SCI(E) journal publications, and achieved an H-index of 35. Her expertise extends to consultancy and industry projects, editorial roles in Frontiers in Bioscience-Landmark and Diseases & Research, and authorship of two books. She actively collaborates with global researchers and holds leadership positions, including Chairperson of the Academic Committee of the Korean Pharmaceutical Society and President of the Woman Bioscience Forum, mentoring future scientists.

๐ŸŒResearch and Innovations:ย 

Professor. Eun Sook Hwang has made significant contributions to immunology, cell biology, and pharmacology through her extensive research and innovations. She has led 12 national research projects and published 105 SCI(E) journal articles, accumulating 4,867 citations with an H-index of 35. Her studies on immune regulation, T-cell differentiation, and inflammation have paved the way for novel therapies in autoimmune diseases, cancer, and fibrosis. She has authored two books, contributed to three industry projects, and holds editorial roles in prestigious journals. Her global collaborations and research on small molecules and tissue regeneration have advanced drug development and biomedical science.

๐Ÿ’กRecognition and Impact:

Professor. Eun Sook Hwang has received numerous accolades for her groundbreaking contributions to immunology, cell biology, and pharmacology. Her extensive research, spanning 105 SCI(E) publications and 12 nationally funded projects, has earned global recognition. She holds editorial positions in Frontiers in Bioscience-Landmark and Diseases & Research and has collaborated with leading institutions such as NIH and NYU Langone. As Chairperson of the Academic Committee of the Korean Pharmaceutical Society and President of the Woman Bioscience Forum, she has been honored for her leadership and mentorship. Her dedication to scientific excellence continues to shape biomedical research and innovation worldwide.

Conclusion:

Professor. Hwangโ€™s exemplary research output, leadership in scientific communities, and dedication to mentoring future researchers make her a highly suitable candidate for the Best Researcher Award. Her pioneering studies have significantly influenced biomedical research, fostering innovation and scientific progress on a global scale

 

๐Ÿ“šPublication Top Notes

TAZ, a transcriptional modulator of mesenchymal stem cell differentiation

Citation: 1190

Year: 2005

๐Ÿ“‘๐Ÿงฌ

T helper cell fate specified by kinase-mediated interaction of T-bet with GATA-3

Citation: 759

Year: 2005

๐Ÿ”ฌ๐Ÿงฌ

T-bet represses TH17 differentiation by preventing Runx1-mediated activation of the gene encoding RORฮณt

Citation: 520

Year: 2011

๐Ÿงฌ๐Ÿ“š

TBX21: a functional variant predicts improvement in asthma with the use of inhaled corticosteroids

Citation: 236

Year: 2004

๐ŸŒฟ๐Ÿ’จ

Shear stress induced by an interstitial level of slow flow increases the osteogenic differentiation of mesenchymal stem cells through TAZ activation

Citation: 222

Year: 2014

โš™๏ธ๐Ÿฆด

IL-2 production in developing Th1 cells is regulated by heterodimerization of RelA and T-bet and requires T-bet serine residue 508

Citation: 192

Year: 2005

๐Ÿงฌ๐Ÿฆ 

T-bet-dependent expression of osteopontin contributes to T cell polarization

Citation: 179

Year: 2005

๐Ÿ”ฌ๐Ÿฆ 

Extracellular matrix stiffness regulates osteogenic differentiation through MAPK activation

Citation: 133

Year: 2015

๐Ÿงฌโš™๏ธ

T-bet polymorphisms are associated with asthma and airway hyperresponsiveness

Citation: 133

Year: 2006

๐ŸŒฟ๐Ÿ’จ

Spontaneous and aging-dependent development of arthritis in NADPH oxidase 2 deficiency through altered differentiation of CD11b+ and Th/Treg cells

Citation: 131

Year: 2011

๐Ÿงฌ๐Ÿฆด